Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Neglected Tropical Diseases Drugs and Vaccine Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Neglected Tropical Diseases Drugs and Vaccine Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Malaria
    • 1.4.3 Ebola
    • 1.4.4 Dengue
    • 1.4.5 Chagas
    • 1.4.6 Leishmaniasis
    • 1.4.7 Other
  • 1.5 Market by Application
    • 1.5.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Application: 2020 VS 2026
    • 1.5.2 Drugs
    • 1.5.3 Vaccines
  • 1.6 Coronavirus Disease 2019 (Covid-19): Neglected Tropical Diseases Drugs and Vaccine Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Neglected Tropical Diseases Drugs and Vaccine Industry
      • 1.6.1.1 Neglected Tropical Diseases Drugs and Vaccine Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Neglected Tropical Diseases Drugs and Vaccine Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Neglected Tropical Diseases Drugs and Vaccine Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Neglected Tropical Diseases Drugs and Vaccine Market Perspective (2015-2026)
  • 2.2 Neglected Tropical Diseases Drugs and Vaccine Growth Trends by Regions
    • 2.2.1 Neglected Tropical Diseases Drugs and Vaccine Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Neglected Tropical Diseases Drugs and Vaccine Historic Market Share by Regions (2015-2020)
    • 2.2.3 Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Neglected Tropical Diseases Drugs and Vaccine Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Neglected Tropical Diseases Drugs and Vaccine Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Market Size
    • 3.1.1 Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Revenue (2015-2020)
    • 3.1.2 Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Concentration Ratio
    • 3.2.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Neglected Tropical Diseases Drugs and Vaccine Revenue in 2019
  • 3.3 Neglected Tropical Diseases Drugs and Vaccine Key Players Head office and Area Served
  • 3.4 Key Players Neglected Tropical Diseases Drugs and Vaccine Product Solution and Service
  • 3.5 Date of Enter into Neglected Tropical Diseases Drugs and Vaccine Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Neglected Tropical Diseases Drugs and Vaccine Historic Market Size by Type (2015-2020)
  • 4.2 Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Type (2021-2026)

5 Neglected Tropical Diseases Drugs and Vaccine Breakdown Data by Application (2015-2026)

  • 5.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2015-2020)
  • 5.2 Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Neglected Tropical Diseases Drugs and Vaccine Market Size (2015-2020)
  • 6.2 Neglected Tropical Diseases Drugs and Vaccine Key Players in North America (2019-2020)
  • 6.3 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2015-2020)
  • 6.4 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size (2015-2020)
  • 7.2 Neglected Tropical Diseases Drugs and Vaccine Key Players in Europe (2019-2020)
  • 7.3 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2015-2020)
  • 7.4 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2015-2020)

8 China

  • 8.1 China Neglected Tropical Diseases Drugs and Vaccine Market Size (2015-2020)
  • 8.2 Neglected Tropical Diseases Drugs and Vaccine Key Players in China (2019-2020)
  • 8.3 China Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2015-2020)
  • 8.4 China Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Neglected Tropical Diseases Drugs and Vaccine Market Size (2015-2020)
  • 9.2 Neglected Tropical Diseases Drugs and Vaccine Key Players in Japan (2019-2020)
  • 9.3 Japan Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2015-2020)
  • 9.4 Japan Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Market Size (2015-2020)
  • 10.2 Neglected Tropical Diseases Drugs and Vaccine Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2015-2020)

11 India

  • 11.1 India Neglected Tropical Diseases Drugs and Vaccine Market Size (2015-2020)
  • 11.2 Neglected Tropical Diseases Drugs and Vaccine Key Players in India (2019-2020)
  • 11.3 India Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2015-2020)
  • 11.4 India Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Neglected Tropical Diseases Drugs and Vaccine Market Size (2015-2020)
  • 12.2 Neglected Tropical Diseases Drugs and Vaccine Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2015-2020)
  • 12.4 Central & South America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Artecef BV
    • 13.1.1 Artecef BV Company Details
    • 13.1.2 Artecef BV Business Overview and Its Total Revenue
    • 13.1.3 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Introduction
    • 13.1.4 Artecef BV Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020))
    • 13.1.5 Artecef BV Recent Development
  • 13.2 GlaxoSmithKline
    • 13.2.1 GlaxoSmithKline Company Details
    • 13.2.2 GlaxoSmithKline Business Overview and Its Total Revenue
    • 13.2.3 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Introduction
    • 13.2.4 GlaxoSmithKline Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020)
    • 13.2.5 GlaxoSmithKline Recent Development
  • 13.3 AstraZeneca
    • 13.3.1 AstraZeneca Company Details
    • 13.3.2 AstraZeneca Business Overview and Its Total Revenue
    • 13.3.3 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Introduction
    • 13.3.4 AstraZeneca Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020)
    • 13.3.5 AstraZeneca Recent Development
  • 13.4 Novartis
    • 13.4.1 Novartis Company Details
    • 13.4.2 Novartis Business Overview and Its Total Revenue
    • 13.4.3 Novartis Neglected Tropical Diseases Drugs and Vaccine Introduction
    • 13.4.4 Novartis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020)
    • 13.4.5 Novartis Recent Development
  • 13.5 Sanofi-Aventis
    • 13.5.1 Sanofi-Aventis Company Details
    • 13.5.2 Sanofi-Aventis Business Overview and Its Total Revenue
    • 13.5.3 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Introduction
    • 13.5.4 Sanofi-Aventis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020)
    • 13.5.5 Sanofi-Aventis Recent Development
  • 13.6 Ranbaxy Labs
    • 13.6.1 Ranbaxy Labs Company Details
    • 13.6.2 Ranbaxy Labs Business Overview and Its Total Revenue
    • 13.6.3 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Introduction
    • 13.6.4 Ranbaxy Labs Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020)
    • 13.6.5 Ranbaxy Labs Recent Development
  • 13.7 Lupin
    • 13.7.1 Lupin Company Details
    • 13.7.2 Lupin Business Overview and Its Total Revenue
    • 13.7.3 Lupin Neglected Tropical Diseases Drugs and Vaccine Introduction
    • 13.7.4 Lupin Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020)
    • 13.7.5 Lupin Recent Development
  • 13.8 Macleods Pharmaceuticals
    • 13.8.1 Macleods Pharmaceuticals Company Details
    • 13.8.2 Macleods Pharmaceuticals Business Overview and Its Total Revenue
    • 13.8.3 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Introduction
    • 13.8.4 Macleods Pharmaceuticals Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020)
    • 13.8.5 Macleods Pharmaceuticals Recent Development
  • 13.9 Cipla
    • 13.9.1 Cipla Company Details
    • 13.9.2 Cipla Business Overview and Its Total Revenue
    • 13.9.3 Cipla Neglected Tropical Diseases Drugs and Vaccine Introduction
    • 13.9.4 Cipla Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020)
    • 13.9.5 Cipla Recent Development
  • 13.10 Romark Laboratories
    • 13.10.1 Romark Laboratories Company Details
    • 13.10.2 Romark Laboratories Business Overview and Its Total Revenue
    • 13.10.3 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Introduction
    • 13.10.4 Romark Laboratories Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020)
    • 13.10.5 Romark Laboratories Recent Development
  • 13.11 Toyama Chemica
    • 10.11.1 Toyama Chemica Company Details
    • 10.11.2 Toyama Chemica Business Overview and Its Total Revenue
    • 10.11.3 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Introduction
    • 10.11.4 Toyama Chemica Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020)
    • 10.11.5 Toyama Chemica Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global Neglected Tropical Diseases Drugs and Vaccine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Neglected Tropical Diseases Drugs and Vaccine development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    Artecef BV
    GlaxoSmithKline
    AstraZeneca
    Novartis
    Sanofi-Aventis
    Ranbaxy Labs
    Lupin
    Macleods Pharmaceuticals
    Cipla
    Romark Laboratories
    Toyama Chemica

    Market segment by Type, the product can be split into
    Malaria
    Ebola
    Dengue
    Chagas
    Leishmaniasis
    Other
    Market segment by Application, split into
    Drugs
    Vaccines

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Neglected Tropical Diseases Drugs and Vaccine status, future forecast, growth opportunity, key market and key players.
    To present the Neglected Tropical Diseases Drugs and Vaccine development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of Neglected Tropical Diseases Drugs and Vaccine are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now